Anti-inflammatory vs. Prolotherapy for Knee Osteoarthritis
Part of Bones, joints & muscles clinical trials.
This study tests whether anti-inflammatory medications or dextrose prolotherapy (sugar water injections) can reduce knee pain and improve function in people with knee osteoarthritis. If you are a military healthcare beneficiary with moderate to severe knee pain, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a Department of Defense healthcare beneficiary receiving care at the David Grant Medical Center.
- You are between 45 and 75 years old.
- You have knee osteoarthritis diagnosed by a doctor, with X-ray showing moderate arthritis (grade 2 or 3).
- You have had moderate to severe knee pain for at least 3 months (pain score of 4 or higher out of 10).
- You have not had knee surgery (like replacement or meniscus repair) and no knee injection in the last 3 months.
- You are not pregnant or breastfeeding, and you have no allergy to dextrose, lidocaine, or sulfites.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to give dextrose injections for knee osteoarthritis: one into the joint space and one guided by MRI into the tissues around the knee. It aims to see which approach works better for pain and function.
This trial tests whether injecting a sugar-water solution around the nerves of the knee can reduce chronic pain from osteoarthritis. It is for people with long-term knee pain, stiffness, and cracking who have not had recent knee treatments or surgery.
This study compares three different injection treatments for knee osteoarthritis: a steroid (cortisone), dextrose prolotherapy (sugar water), and platelet-rich plasma (using your own blood). The goal is to see which works best for long-term pain relief and joint function.
This study compares two different types of knee injections for people with knee osteoarthritis. One injection uses a simple sugar solution (dextrose), and the other uses a standard numbing medication (local anesthetic). The goal is to see which works better for reducing pain and improving knee function.
This study tests a new injection called 2107 to see if it helps reduce pain and improve function in people with mild to moderate knee osteoarthritis. If you're eligible, you'll receive the injection and be monitored for several months to see how it works.
This trial compares two types of injections—one standard anti-inflammatory drug and one simple sugar water solution—to see which works better for treating low back pain in an emergency setting. If you are an adult between 18 and 55 with isolated low back pain, this study may help find a more effective pain treatment.
Hear when a new Knee Osteoarthritis (OA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.